Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2003
10/09/2003CA2479914A1 Meloxicam suppositories containing e.g. polyethylenglycol
10/09/2003CA2479912A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
10/09/2003CA2479910A1 N-{ '(2s) -4- (3, 4-difluorobenzyl) morpholin-2yl]methyl} -2-{3-' (methylsulphonyl) amino] phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479647A1 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003CA2479644A1 Imidazo fused compounds
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2477751A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/08/2003EP1350848A2 T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350514A2 Therapeutic use of cis-element decoys in vivo
10/08/2003EP1350512A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/08/2003EP1350435A2 Compositions and methods for promoting lipid assimilation in pets
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349939A2 Aminoacyl trna synthetases
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349874A2 Peptide and polypeptide inhibitors of complement c1s
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349864A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349842A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349836A2 Tetracyclic derivatives as spla2 inhibitors
10/08/2003EP1349834A2 Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349557A2 Fractions of snake blood, their preparation and use as therapeutic agents
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349549A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1349541A1 Self emulsifying lipid matrix (selm)
10/08/2003EP1349540A2 Topical alcoholic solution of a salicylic acid derivative and acemannan
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1144421B1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases
10/08/2003EP1001935B1 Indole derivatives as mcp-1 receptor antagonists
10/08/2003EP0966245B1 Antimicrobial cosmetic compositions
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447919A Use of antibodies against specific MHC-Peptide complexes
10/08/2003CN1447811A Medicinal compsns. and its use
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447792A Aporphine esters and their use in therapy
10/08/2003CN1447788A Process for prodn. of calcium pantothenate
10/08/2003CN1447699A Peptide and peptide minetic conjugates with integrin-inhibitor properties
10/08/2003CN1446576A Adhibition film for acesodyne and apocatastasis caused by intramuscular injection
10/08/2003CN1446572A Granule of ÔÇÿJingangtengÔÇÖ for treating inflammatory gynecopathy and its preparation method
10/08/2003CN1446567A Pill for relaxing muscles and activating collateral flow
10/08/2003CN1446561A Medicine for rehabilitation from osteomyelitis
10/08/2003CN1446558A Blaster for treating rheumatoid arthritis
10/08/2003CN1446554A Medicine for treating acute cholecystitis and chronic cholecystitis and its preparing method
10/08/2003CN1446538A Aaalgesic prepared Chinese medicine with non-addiction and its preparing technique method
10/08/2003CN1123564C Anti-inflammatory compounds
10/08/2003CN1123348C Capsule for treating rheumatic and rheumatoid arthritis and its preparing process
10/07/2003US6630573 Tau-conotoxin peptides
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630505 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630501 Phosphinic pseudo-peptides that may be used as matrix zinc metalloprotease inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630473 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630458 Teat dipping agent
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630128 Insoluble support
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2244402C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA2140890C Medicament for inhibiting neutrophil elastase and cathepsin g
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080633A1 Novel $g(a)-amino-n-(diaminophosphinyl)lactam derivative
10/02/2003WO2003080626A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080619A1 Fused bicyclic pyrimidine derivatives
10/02/2003WO2003080613A1 Process for the preparation of intermediates in the synthesis of 2- (purin-9-yl) - tetrahydrofuran-3,4-diol derivatives
10/02/2003WO2003080611A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
10/02/2003WO2003080610A1 Imidazopyridine derivatives as kinase inhibitors
10/02/2003WO2003080609A1 Pyrazolopyrimidines derivatives
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives